advancing healthcare Meril Unveils Promising One-Year Results from Landmark TAVI Trial at EuroPCR 2025 Meril presents one-year outcomes from the LANDMARK trial at EuroPCR 2025, showcasing the Myval THV series' safety, efficacy, and global relevance in TAVI treatment.
Meril Meril, Japan Lifeline Launch Myval Octacor Heart Valve Meril Life Sciences and Japan Lifeline join forces to bring Myval Octacor, a cutting-edge transcatheter heart valve, to Japan, marking a significant stride in elevating cardiac treatment pending regulatory clearance.
